InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,957.51
(
0.10%
)
Post# of 284
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 467
Posts 26918
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 164

Wednesday, 05/23/2012 10:52:56 AM

Wednesday, May 23, 2012 10:52:56 AM

Post# of 284
9:02AM Seattle Genetics announces Health Canada accepts ADCETRIS new drug submission for review (SGEN) 20.42 : Co announced that the validation period is complete and Health Canada has accepted for review its New Drug Submission for the use of ADCETRIS in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. The NDS will be reviewed under the Health Canada policy of Notice of Compliance with Conditions. ADCETRIS is an antibody-drug conjugate directed to CD30, which is expressed in Hodgkin lymphoma and sALCL. The NDS is based on results from a pivotal trial in HL patients with relapsed or refractory disease following an autologous stem cell transplant and a pivotal trial in relapsed or refractory sALCL patients.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SGEN News
More SGEN News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!